Sarah Boyce - Insider Trading & Ownership

Location
C/O Ionis Pharmaceuticals, Inc., 2855 Gazelle Court, Carlsbad, CA
Summary
The estimated net worth of Sarah Boyce is at least $15.8M dollars as of September 5, 2025. Sarah Boyce is the President and CEO, Director of Avidity Biosciences, Inc. and owns shares of Avidity Biosciences, Inc. (RNA) stock worth about $15.3M. Sarah Boyce is the Director of OmniAb, Inc. and owns shares of OmniAb, Inc. (OABI) stock worth about $302K. Sarah Boyce is the Former Director of LIGAND PHARMACEUTICALS INC and owns shares of LIGAND PHARMACEUTICALS INC (LGND) stock worth about $209K. Sarah Boyce is the Director of Berkeley Lights, Inc. and owns shares of Bruker Cellular Analysis, Inc. stock worth about $770.
Signature
/s/ John B. Moriarty, Jr., J.D., Attorney-in-Fact
All Insider Reports
All Insider Reports

Ownership of Sarah Boyce

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
RNA Avidity Biosciences, Inc. President and CEO, Director $15.3M -$6.05M -28.4% Sep 5, 2025
OABI, OABIW OmniAb, Inc. Director $302K Jun 18, 2024
LGND, LGNDZ LIGAND PHARMACEUTICALS INC Former Director $209K Nov 1, 2022
BLI Bruker Cellular Analysis, Inc. Director $770 May 14, 2021
CTNM Contineum Therapeutics, Inc. Director Jun 26, 2025

Insider Transactions Reported by Sarah Boyce:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.